Finding 1093124 (2024-007)

Material Weakness
Requirement
HL
Questioned Costs
$1
Year
2024
Accepted
2024-12-23

AI Summary

  • Core Issue: A financial report inaccurately stated that $381,630 in grant funds were unobligated, leading to improper carryover into the next grant period.
  • Impacted Requirements: The Organization failed to comply with 45 CFR 75.342 and 45 CFR 75.309 regarding accurate reporting of federal funding and program income.
  • Recommended Follow-Up: Revise the annual Federal Financial Report and ensure future reports are based on accurate accrual-basis financial information to prevent similar errors.

Finding Text

Health Center Program Cluster – Assistance Listing Nos. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. 6 H80CS00751-22-03, April 1, 2023 – March 31, 2024 Criteria or Specific Requirement – Reporting and Period of Performance – 45 CFR 75.342 and 45 CFR 75.309. Condition – A financial report submitted during the year was not prepared accurately based on financial information. As a result, grant funds were carried over into the subsequent grant budget period even though allowable costs had been incurred. Questioned Costs – $381,630. Questioned costs were determined based on the amount of grant expenditures reported as unobligated but incurred by March 31, 2023. Context – The Organization is required to report federal funding awarded and expended, along with program income earned and expended, on annual Federal Financial Reports (FFRs) for each federal award. A sample of one FFR was tested out of a population of four financial reports submitted by the Organization during the year. Samples were not, and were not intended to be, statistically valid. Federal funding expended was understated by $381,630, the amount of grant expenditures incurred, but not disbursed at year-end, on the annual FFR for Award No. 6 H80CS00751, resulting in an overstatement of the unobligated balance at March 31, 2023, and carryover of grant funds into the grant period ending March 31, 2024. Additionally, the Organization failed to report program income earned and expended cumulatively. Effect – The Organization improperly reported $381,630 of grant funds as unobligated at March 31, 2023, resulting in the carryover of grant funds into the grant period ending March 31, 2024, although funds had already been obligated as of March 31, 2023. The Organization’s cumulative tracking of unearned program income and, therefore, its reserve, is not accurate. Cause – The annual FFR was not prepared based on accurate accrual-basis and cumulative financial information. Identification as a repeat finding, if applicable – Not a repeat finding Recommendation – The Organization should consider revising the annual FFR due to inappropriate carryover of obligated grant funds. Going forward, the Organization should ensure financial reporting is prepared based on accurate accrual-basis financial information and, where appropriate, presented cumulatively. Views of responsible officials and planned corrective actions – The Organization is unable to amend its erroneously submitted FFR. As funds that had already been spent on expenditures within the initial period of performance were erroneously reported as needing to be carried over, no reallocation of grant expenditures was needed. The Organization has also reviewed our internal process for FFR submission. In general, we do not have carryover on our FFR, and this error occurred due to the additional Covid-19 funding the organization had received. Relevant staff participated in a training focused on CHC grants management matters, including preparation of the FFR, in December 2024 and will continue to look for learning opportunities to support and challenge compliance matters.

Categories

Questioned Costs Reporting Allowable Costs / Cost Principles

Other Findings in this Audit

  • 516671 2024-003
    Significant Deficiency
  • 516672 2024-003
    Significant Deficiency
  • 516673 2024-004
    Significant Deficiency
  • 516674 2024-005
    Significant Deficiency
  • 516675 2024-005
    Significant Deficiency
  • 516676 2024-005
    Significant Deficiency
  • 516677 2024-005
    Significant Deficiency
  • 516678 2024-006
    Significant Deficiency
  • 516679 2024-006
    Significant Deficiency
  • 516680 2024-006
    Significant Deficiency
  • 516681 2024-006
    Significant Deficiency
  • 516682 2024-007
    Material Weakness
  • 516683 2024-007
    Material Weakness
  • 516684 2024-008
    Significant Deficiency
  • 516685 2024-008
    Significant Deficiency
  • 516686 2024-008
    Significant Deficiency
  • 516687 2024-008
    Significant Deficiency
  • 1093113 2024-003
    Significant Deficiency
  • 1093114 2024-003
    Significant Deficiency
  • 1093115 2024-004
    Significant Deficiency
  • 1093116 2024-005
    Significant Deficiency
  • 1093117 2024-005
    Significant Deficiency
  • 1093118 2024-005
    Significant Deficiency
  • 1093119 2024-005
    Significant Deficiency
  • 1093120 2024-006
    Significant Deficiency
  • 1093121 2024-006
    Significant Deficiency
  • 1093122 2024-006
    Significant Deficiency
  • 1093123 2024-006
    Significant Deficiency
  • 1093125 2024-007
    Material Weakness
  • 1093126 2024-008
    Significant Deficiency
  • 1093127 2024-008
    Significant Deficiency
  • 1093128 2024-008
    Significant Deficiency
  • 1093129 2024-008
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $1.74M
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $92,685
21.027 Coronavirus State and Local Fiscal Recovery Funds $81,304
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated and State Partnership Marketplaces $35,027
93.307 Minority Health and Health Disparities Research $13,411
93.268 Immunization Cooperative Agreements $685